Quick Answer
Gotu Kola Anxiety Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background In Persian Medicine topical use of chamomile and dill oils were used for obesity treatments.
Key Takeaways
- 01Background In Persian Medicine topical use of chamomile and dill oils were used for obesity treatments. [Bashiri M (2025)]
- 02The aim of this study was to investigate the effect of topical use of chamomile and dill oils on abdominal obesity. [Bashiri M (2025)]
- 03Results The results indicated significant improvements across all domains over time (p Conclusions This exploratory research indicates that the trial kit was feasible, well tolerated, and associated with improvements in exploratory cognitive measures and perceived well-being over an eight-week period, although practice and placebo effects cannot be ruled out. [Al-Ghananeem AM (2026)]
- 04Aims This study used an open-label design, comprising a one-arm eight-weeks-long study, and aimed to evaluate patient satisfaction and the efficacy of a novel dietary supplement composition combined with probiotic and omega-3 to support brain health improvement in 39 participants with confirmed or suspected brain fog caused by trauma, disease, exposure to chemotherapeutics, or similar events. [Al-Ghananeem AM (2026)]
The current Migaku evidence database contains 2 reusable source documents for Gotu Kola Anxiety Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Background In Persian Medicine topical use of chamomile and dill oils were used for obesity treatments. [Bashiri M (2025); evidence level 2]
- The aim of this study was to investigate the effect of topical use of chamomile and dill oils on abdominal obesity. [Bashiri M (2025); evidence level 2]
- Results The results indicated significant improvements across all domains over time (p Conclusions This exploratory research indicates that the trial kit was feasible, well tolerated, and associated with improvements in exploratory cognitive measures and perceived well-being over an eight-week period, although practice and placebo effects cannot be ruled out. [Al-Ghananeem AM (2026); evidence level 4]
- Aims This study used an open-label design, comprising a one-arm eight-weeks-long study, and aimed to evaluate patient satisfaction and the efficacy of a novel dietary supplement composition combined with probiotic and omega-3 to support brain health improvement in 39 participants with confirmed or suspected brain fog caused by trauma, disease, exposure to chemotherapeutics, or similar events. [Al-Ghananeem AM (2026); evidence level 4]
- Methods The primary measure was the change from baseline in survey scores of the Montreal Cognitive Assessment. [Al-Ghananeem AM (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources